Escalated dosing schedules of CC-486 for patients experiencing first acute myeloid leukemia (AML) relapse: Results from the phase III QUAZAR AML-001 maintenance trial.

Autores de IIS La Fe

• Pau Montesinos Fernández

  Autor

Participantes ajenos a IIS La Fe

• Dohner, H
• Wei, A
• Dombret, H
• Ravandi, F
• Sayar, H
• Porkka, K
• Sandhu, I
• Passamonti, F
• Pane, F
• Robak, T
• Falantes, JF
• Schuh, AC
• Ossenkoppele, GJ
• La Torre, I
• Skikne, B
• Kumar, K
• Dong, Q
• Beach, CL
• Roboz, GJ

Grupos

• Hematología y Hemoterapia

Abstract

Abstract no disponible